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INTRODUCTION 
 
An estimated 79 million Americans are infected with the human 
papillomavirus (HPV). An additional 14 million people are infected each 
year, and most sexually active people will contract HPV at some point in 
their life.1 Every year there are over 33,000 cancers caused by HPV, most 
commonly cervical cancer in women and oropharyngeal cancers in men.2 
In 2006, the Food and Drug Administration (FDA) approved a 
vaccine that was subsequently recommended for routine vaccination by the 
Advisory Committee for Immunization Practices (ACIP) for adolescent girls 
and later boys at ages 11 and 12 years. Vaccination at this age is 
recommended because the immune response is stronger at younger ages 
and because the vaccine should be administered before the initiation of 
sexual activity and exposure to HPV. It is also recommended for females 
ages 13-26 and males ages 13-21 not previously vaccinated.3,4 Awareness 
of the vaccine has increased since its introduction to the market. However, 
as of 2017, 39% of adolescent males and females were up to date with the 
vaccine series by age 13 and 49% of 13- to 17-year-olds were up to date 
compared to the 80% completion goal established by Healthy People 
2020.5,6 
Missed clinical opportunities are reported as the primary factor for 
not achieving higher rates of HPV vaccination.7 Parents have indicated that 
the most important determinants of having their child vaccinated are having 
their healthcare provider recommend it, talking with a doctor, having time to 
discuss it, and visiting their healthcare provider in the past year.8–13 Studies 
have corroborated this finding by showing that receiving a strong 
recommendation from their healthcare provider was the most important 
factor in parents’ decision to vaccinate their child.14,15  Parents’ lack of 
information has been cited as a key barrier, and perceived satisfaction in 
the quality of information they receive is associated with uptake of the 
vaccine.16–18  
Researchers at the University of Texas Health Science Center at 
Houston (UTHealth) and Baylor College of Medicine (BCM) in collaboration 
with Texas Children’s Pediatrics (TCP) implemented evidence-based 
strategies to increase HPV vaccination rates in the Houston, Texas area. 
This multicomponent program consisted of provider assessment and 
feedback, provider reminders, and provider education components to 
increase provider recommendation of the vaccine, and parent education 
and reminders to provide quality information about HPV, HPV vaccination, 
and vaccination recommendations. 
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The purpose of this analysis was to examine costs, from the 
clinic/network perspective, associated with program implementation in a 
large pediatric clinic network with a sensitivity analysis examining effects of 
varying program implementation. As providers and healthcare 
organizations consider vaccination initiatives, it is important for decision 
makers to understand costs associated with implementing and recruiting 
patients/guardians for various components of these programs in their 
respective organizations. 
 
METHODS 
 
Study Description 
 
This prospective cost analysis was conducted alongside the delivery of a 
multicomponent program to increase HPV vaccination in a network of 
pediatric clinics in a 5-county area around Houston from October 2015 
through February 2018. The Adolescent Vaccination Project (AVP) 
consisted of four sequentially implemented components: assessment and 
feedback, provider education, provider/parent reminders, and parent 
education.   
The TCP network includes 51 pediatric primary care clinics affiliated 
with Texas Children’s Hospital and serves approximately 20% of the greater 
Houston metropolitan area pediatric population with over 200 physicians 
and 800 clinical staff. The average clinic has 19 clinical staff including 
physicians, nurse practitioners, nurses, and medical assistants. Over 
152,000 unique patients between the ages of 11 and 17 were eligible to 
receive the HPV vaccine during the study period.  
Immunization champions serving as liaisons between researchers 
and their respective clinic distributed tailored assessment and feedback 
(A&F) reports highlighting individual physician and aggregate clinic 
vaccination rates. The reports allowed providers to compare their 
vaccination rates with other clinics as well as national goals. One year after 
A&F implementation, the provider education program was introduced to all 
clinical staff.  We developed a one-hour online continuing education (CE) 
session based on a preliminary needs assessment to relay the most current 
information regarding HPV and HPV vaccination and provide best practices 
for communicating with parents addressing potential barriers to 
immunization. The final system-level program was an automated reminder 
system for both providers and parents. Providers received reminders 
through the electronic health record (EHR) indicating if a patient was due or 
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overdue for a dose of HPV vaccine. Parents received similar reminders 
through the network’s patient portal. 
In addition to system-level strategies, parents were recruited to 
participate in a parent education program based on clinic randomization. A 
mobile application (app) specific to TCP presented several modules 
describing HPV, HPV vaccine, testimonials from network providers and 
parents, and tools to schedule their next appointment and receive 
appointment reminders through alerts on their mobile device.  
 
Cost Estimation 
 
In 2018, we used micro-costing at the clinic level to estimate program fixed 
and variable costs. This detailed and time-intensive method provides the 
most precise  estimate of actual costs compared to gross costing, which 
depends on the price of services provided in the healthcare market and 
which may not be available for new services.19  
Fixed costs were incurred prior to service delivery. These comprised 
contract services from third-party vendors to 1) implement automated EHR 
vaccination reminders for providers and parents, and 2) produce a network-
tailored mobile application to educate parents on HPV and HPV vaccination. 
Fixed costs also included training costs. Variable costs consisted of staff 
time, supplies, and recruitment necessary to implement each strategy. With 
the clinic as the primary unit of analysis, we estimated an average cost per 
clinic by distributing fixed costs evenly among all clinics. Because of 
variation in the number of providers at each clinic, variable average costs 
were weighted on clinic resource utilization. 
 
Variable Cost  
 
We calculated the cost of time spent by project staff, clinic staff, and parents 
receiving the program by multiplying an estimated per-minute rate 
measured in US dollars by their time spent implementing tasks or 
participating in the education programs. Project staff pay rates and time 
available for implementation of tasks were adjusted by accounting for fringe 
benefits and estimated productivity rates (Table 1). Previous studies have 
used an 85% productivity rate largely based on Urban et al (1990)20.  Since 
mid-1990, the US has seen significant growth in the average annual labor 
productivity due to capital investments in information technology along with 
innovative work processes.21 A more recent analysis by Burda et al. (2015) 
used the American Time Use Survey (ATUS) 2003-2012, where sample 
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respondents reported spending 7% of their time at work not working.22 
Hence, productivity was assumed as 93% in this analysis. 
Project staff time was self-reported using logs measuring time spent 
training immunization champions, maintaining clinic staff rosters, producing 
quarterly A&F reports, and producing additional resources including fact 
sheets and champion binders.  
Clinic staff per-minute rates were estimated by averaging actual pay 
rates from a sample of 120 clinical staff representing all job classifications. 
Time spent by clinical staff implementing the different strategies was 
collected in two ways. First, immunization champions reported the time 
spent distributing and discussing the A&F reports with their peers using time 
logs. Second, we captured time spent completing the online CE using 
system-generated completion reports and multiplying the participants 
estimated wage rate by the duration of the learning module.  
Material costs were captured by multiplying the number of pages 
printed for the A&F reports, training materials, and additional resources by 
the cost per page and then adding additional supplies where appropriate. 
Postage costs were incurred with the first two quarterly A&F reports; 
however, subsequent reports were sent via TCP’s inter-institutional 
mailroom at no cost to the project. Because the reminder and educational 
programs were delivered electronically, material costs associated with 
these strategies were not incurred.  
 
Fixed Cost 
 
Third-party vendors were contracted to program and implement provider 
and parent reminders in the EHR and produce the mobile APP for the parent 
education program. Contractors created a pediatric EHR wellness registry 
on which an algorithm was applied to inform providers on patient’s HPV 
vaccination status and whether any doses of HPV vaccine were due. The 
same registry and algorithm were used to notify parents of their child’s HPV 
vaccination status through the online patient portal. App developers 
designed, tested, launched, and maintained the network-specific parent 
education program on multiple mobile platforms.  
Parents were required to complete an online survey to participate in 
the parent education component. This contact method generated 
recruitment costs of only parents eligible to receive the education 
component based on the clinic they identified with. Because this analysis is 
from the clinic/network perspective, parent time spent engaging in the 
recruitment process was excluded. However, monetary incentives received 
via an electronic gift card were included as their cost was born by the 
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program to attract participants.  Also included were time and mileage of 
project staff incurred inviting parents to the program and visiting clinics to 
actively recruit participants at clinics randomized to receive the parent 
education component.  
 
RESULTS 
 
Program Implementation 
 
Total program implementation costs between October 2015 and February 
2018 totaled $157,534. The average cost per clinic (n=51) was $4749 
weighted on clinic size and staff participation. In aggregate, the average 
cost per HPV vaccination-eligible adolescent was about $1. 
Quarterly A&F reports were delivered to 6 pilot clinics beginning in 
February 2016 with full rollout to all clinics in May 2016 at a total cost of 
$35,334 and average cost of $786 per clinic (Table 2). Costs were 
categorized by personnel time spent producing and distributing the A&F 
reports, material costs, and binders provided to keep each respective 
clinic’s reports. Time spent by project and clinic staff producing and 
distributing the A&F reports totaled $21,611 and $7935, respectively. The 
cost of the packets was $4683 and $1105 for the champion binders totaling 
$5788 in material costs. Average costs per clinic were $660 and $125 for 
personnel time and materials, respectively. Time costs represented 84% of 
the total A&F implementation cost with 73% of that representing the time 
spent extracting vaccination rates from the EHR composing the reports, and 
compiling them into packets for each of the 51 clinics.  
A total of 221 clinical staff completed the 1-hour online course at a 
total cost of $10,225 in personal time and an average of $368 per clinic 
(Table 2). The largest share, $6699 (66%), resulted from 55 physicians 
(25%) completing the course and having the highest wage rate. Medical 
assistants (MAs) constituted the largest share of participants (92, or 42%) 
at a cost of $1516 (15%). Nurses (49, or 22%) also completed the course 
costing $1306 (13%). The remainder of participants were made up of a 
combination of nurse practitioners, practice managers, social workers, and 
other clinical support staff. 
Healthcare providers and parents received automated reminders 
through the EHR at a cost of $42,000 for third-party contracted services 
(Table 2). The total cost was not dependent on clinic size and was divided 
equally among all 51 clinics for an average cost of $824.  
The parent education component cost totaled $55,228, representing 
combined contracted services for producing the tailored mobile app (Table 
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2). Fifty-six of the 141 parents intended for treatment utilized the mobile 
education application and averaged less than a minute per parent directed 
to the app. The average contract cost was $2126 per clinic receiving the 
app. Including the parent recruitment cost resulted in a total cost of $63,286 
at an average of $2540 per clinic. 
 
Champion Training and Parent Recruitment 
 
Prior to program rollouts, TCP champions, 2 from each clinic, participated 
in a series of training webinars, 1 for the pilot clinics and 3 for all clinics, 
hosted by UTHealth project staff. Each webinar was approximately 30 
minutes and with a total training cost of $6689 (Table 2). A total of 223 TCP 
staff identified as champions participated in at least 1 of 4 webinars at a 
time cost of $5907, an average cost of $115 per clinic. Due to champion 
turnover throughout the study period, an average of 2 webinars were 
attended by each participant. The cost of hosting and administering the 
training sessions was $782. 
Additionally, variable recruitment costs were incurred to introduce 
the parent education component. Ninety-eight parents were recruited 
through the online survey at a total cost of $8058 with the largest individual 
share coming from incentives paid to participants ($3525, or 44%). The 
remaining $4533 (56%) resulted from recruitment activities including project 
staff time and traveling to clinics, and providing recruitment printed 
materials.   
 
Sensitivity Analysis 
 
There were 3 primary sources of variability in measured costs of program 
implementation: variation in TCP champion participation and wage rates, 
number of parents participating in the parent education, and the methods 
for recruiting participants in the parent education component. A sensitivity 
analysis was conducted using total average costs to demonstrate how costs 
vary with different TCP staff and parent participation.  
A&F implementation costs were estimated under different scenarios 
depending on variation in TCP wage rates under the observed participation 
level. The least costly and costliest scenarios assume observed champion 
participation at the lowest and highest TCP wage rates--medical assistants 
and physicians--that resulted in cost estimates of $633 and $807 per clinic, 
respectively. These were compared to observed wage rates, or base case, 
of $786 per clinic. Assuming the least costly and costliest scenarios, total 
program implementation cost ranges between $151,413 and $162,747 with 
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differences from the observed $157,534 of -$6121 and +$5213, 
respectively. 
The parent component targeted 26 clinics randomly assigned to 
receive the parent education component from among the total 51 clinics. 
We then used simulation to scale up the intervention to all clinics and 
estimate the effect on the total average cost of the parent education. 
Observed weighted average recruitment costs were imputed for the 
additional clinics, resulting in an average variable cost of $360 per clinic. 
Fixed costs were distributed across all 51 clinics, yielding an assumed 
average fixed cost of $1082 per clinic. The total average cost of expanding 
the parent component to all clinics declined from the observed $2540 to an 
estimated $1443 due to broader distribution of fixed costs. Assuming 
average observed cost across the additional 25 clinics, total implementation 
cost increases by $10,350 to $167,884. 
It is assumed recruitment costs through the parent survey would be 
incurred under normal implementation. The sensitivity analysis was 
expanded to consider alternate scenarios, assuming no survey was used 
for recruitment as a minimum, the observed costs as the maximum, and the 
midpoint to estimate a combination or alternate recruitment strategy. 
Incentive cost totaled $3525. Removing this component resulted a 44% 
reduction in recruitment cost to $4533 ($126 per clinic from $414). 
Assuming a midpoint cost savings of $1763, recruitment costs are 
estimated at $6295 ($270 per clinic). Different recruitment strategies may 
have a significant effect on recruitment costs; however, in this case, total 
implementation cost was reduced only about 3% to $154,009 at the 
minimum and only about 1% to $155,771 at the assumed midpoint. 
 
DISCUSSION 
 
Implementation costs were estimated for a multicomponent strategy to 
increase HPV vaccination rates in a large pediatric clinic network. A&F, 
provider education, provider/parent reminders, and parent education 
components were implemented at total average costs of $786, $368, $824, 
and $2126, respectively, per clinic. The AVP program was delivered at a 
total cost of $157,534, or $4749 per clinic. Sixty-six percent ($103,917) of 
the total costs were fixed, including contracted services to produce 
vaccination reminders to providers and parents and the tailored parent 
education mobile app and training costs. The variable costs included 
materials and personal time spent generating and distributing A&F reports 
and time spent participating in the provider education program (29%, 
$45,559) and recruiting parents to the AVP (5%, $8058). Future programs 
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may forgo this recruitment step with the risk of drawing ineligible participants 
and attracting fewer participants. 
 Though excluded from this clinic/network perspective, we estimated 
the time spent by parents engaging with the mobile app and recruitment 
activities and the cost associated with that time. Parents spent an average 
of about 17 minutes, mostly completing the survey. The cost of this time 
totaled $599 completing the recruitment survey and $51 utilizing the 
education app. We found this cost to be minimal, only accounting for about 
0.4% of the total program cost. 
The analysis utilizes the network/clinic as the unit of analysis to 
inform administrators about the costs associated with implementing these 
system-level strategies. Previous studies examining costs of programs to 
increase HPV vaccination rates and cancer screening have focused on 
patients as the unit of analysis. A 2017 study compared 2 HPV vaccination 
intervention strategies for Hispanic parents of daughters aged 9 to 17 years 
old.  The estimated per-participant cost was $88 for the print-based photo 
novella method and $108 for the iPad-based tailored interactive multimedia 
intervention.23 The AVP program was delivered at an estimated $1 per HPV 
vaccine-eligible adolescent, highlighting the advantage of implementing in 
a large clinic network and targeting providers reaching substantially more 
eligible patients than other strategies. For example, over the course of this 
study, 155,000 HPV vaccination-eligible adolescents were seen in TCP 
clinics and 107,165 (69%) initiated the vaccine series. In 2017, about 58% 
of adolescents in Texas had received one or more dose of HPV vaccine 
while about 40% were up to date.24 Though observed vaccine initiation 
during the study period does not meet the Healthy People 2020 goal of 80%, 
it considerably outpaces Texas rates. 
Even though the observed AVP costs per patient are less than those 
of other intervention strategies, the sensitivity analysis shows that the level 
of participation and wage rates have an effect on overall cost to the clinic 
and network for implementing these strategies. Depending on who and how 
many participate in the A&F component, program costs can vary from $633 
to $807 per clinic, compared to the observed $786. This results in a range 
of about $151,413 to $162,747 in total costs. Additionally, expanding the 
parent education component to all 51 clinics reduced the per-clinic average 
cost from $2540 to $1443. Because a large share of the total cost is fixed, 
the overall average cost per clinic is sensitive to the number of clinics and 
parents participating in the program though total program costs increase by 
$10,350 when expanding across all clinics. 
This study has limitations. UTHealth personnel time costs were 
based on self-reported time, and TCP wage rates were based on a sample 
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of actual salaries across all job descriptions. It is also possible for providers 
to complete the education module outside of normal clinic hours, reducing 
clinic costs, and imposing a personal time cost on the provider. Wage 
information for parents was estimated based on census per-capita income 
of the individuals’ zip code. Time spent by providers discussing HPV 
vaccination with patients was not observed and therefore omitted from the 
cost estimates. 
 
CONCLUSION 
 
While HPV vaccination has been shown to be a cost-effective way to 
prevent HPV-related cancers25, the cost of strategies for increasing HPV 
vaccination have not been determined. Provider-based strategies including 
A&F, provider education, and reminders were implemented at costs of 
$35,334, $10,225, and $42,000, respectively, with a complimentary parent 
component introduced to a random sample of clinics costing $55,228. 
Additional training and recruitment costs equaled $6689 and $8058, 
respectively. Fixed costs represented the largest share (66%) of total costs, 
making the results sensitive to the number of participating clinics and 
parents (Figure 1). Future assessments should replicate the cost analysis 
under normal operating conditions with minimal to no external support. This 
research serves to inform implementation scientists and clinic and provider 
network decision-makers on the costs of implementing strategies for 
increasing HPV vaccination among adolescent patient populations. 
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 Table 1. Project Staff Wage Adjustment 
Position Base 
Work 
Hours 
per Year 
Base 
Annual 
Salary 
($) 
Fringe 
Benefit 
Rate 
(1) 
Salary 
and 
Fringe 
(2) 
Salary 
per 
Minute 
(3) 
Total 
Paid 
Time Off 
Hours 
(4) 
Annual 
Hours 
at Work 
(5) 
Annual 
Hours 
Available 
for Tasks 
(6) 
Proportion 
of Paid 
Time 
Available 
for Tasks 
(7) 
Adjusted 
Salary 
per 
Minute 
(8) 
Project manager 2080 70,845 0.27 89,973 0.72 188 1892 1760 0.85 0.85 
Project coordinator 2080 45,320 0.33 60,276 0.48 176 1904 1771 0.85 0.57 
Database manager 2080 66,852 0.33 88,913 0.71 260 1820 1693 0.81 0.88 
Graduate assistant 1040 20,000 0.26 25,200 0.40 40 1000 930 0.89 0.45 
(1) Institution fringe benefit rates  
(2) (Base Salary * Fringe Benefit Rate) + Base Annual Salary 
(3) Per-minute rate of Base Annual Salary excluding fringe benefits. 100% based on 52 wk/y and 40 h/wk. 50% based on 52 wk/y and 20 h/wk. Intern is 10 
wk/y and 40 h/wk. 
(4) 100% employees calculated at 8 h/day and 50% employees calculated at 4 h/day.  
(5) Work hours per Year - Total Paid Time Off Hours 
(6) Annual Hours at work - (Annual Hours at Work * 0.07). Calculation based on 93% productivity rate based on Burda et al.21 
(7) Annual Hours Available for Work / Work Hours per Year 
(8) (Salary and Fringe / Annual Hours Available for Tasks) / 60 
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Table 2. Strategy Implementation Costs 
Resource Input Units 
Variable 
Cost 
Fixed 
Cost 
Average 
Cost per 
Clinic1 
Total Program Implementation  $53,617 $103,917 $4749 
 
Assessment and Feedback (A&F) 
 
$35,334 . $786 
Personal time (min) 34,381 $29,546 . $660 
UT project staff (min) 27,904 $21,611 . $501 
TCP clinic staff (min) 6477 $7935 . $159 
Materials  $5788 . $125 
A&F report packets (packets) 412 $4227 . $95 
Resource packets (packets) 51 $456 . $9 
Champion binders (binders) 51 $1105 . $22 
Provider Education  $10,225 . $368 
TCP staff time (min) 13,260 $10,225 . $368 
Provider Reminders  . $42,000 $824 
Contract services (services)  . $42,000 $824 
Parent Education  $52 $55,228 $2126 
Mobile application (applications)  . $55,228 $2126 
Training  . $6689 $231 
Personal time  . $6689 $231 
UT project staff (min) 700 . $782 $116 
TCP clinic staff (min) 6092 . $5907 $115 
Recruitment  $8058 . $414 
        UT project staff (min) 10,070 $3423 . $101 
Mileage (mi) 1224 $655 . $8 
Incentives (gift cards) 141 $3525 . $288 
Printed materials (pages) 2274 $455 . $17 
1 Assessment and Feedback, Provider Education, and Provider/Parent Reminders were implemented in 51 
clinics. Parent Education was implemented in 26 clinics. 
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Figure 1. Program Cost Distribution 
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